Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties Track

The experience of the dopamine transporter SPECT in three pediatric patients with Neurodegeneration with Brain Iron Accumulation

Ikuko Mochida, Eku Shimosegawa, KEIKO MATSUNAGA, Tadashi Watabe, Kayako Isohashi, Mitsuaki Tatsumi, Hiroki Kato and Jun Hatazawa
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1786;
Ikuko Mochida
7Department of Nuclear Medicine and Tracer Kinetics Osaka University Graduate School of Medicine Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eku Shimosegawa
5Osaka University Graduate School of Medicine Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEIKO MATSUNAGA
4Osaka university graduate school of medicine Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadashi Watabe
8Nuclear Medicine and Tracer Kinetics Osaka University Graduate School of Medicine Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kayako Isohashi
2Suita City Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitsuaki Tatsumi
6Osaka University Graduate School of Medicine Suita/ Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroki Kato
1Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Hatazawa
3Osaka University Graduate School of Medicine Suita, Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1786

Objectives Three Neurodegeneration with Brain Iron Accumulation (NBIA) pediatric patients (2 male, 1 female) had I-123 FP-CIT SPECT in our hospital from January 2014 to December 2015.

Methods According to Japanese consensus guidelines for pediatric nuclear medicine, a dose between 1-2 mCi, based on patient body weight, of I-123 FP-CIT was given intravenously. SPECT imaging was carrie out 3 hours after injection and was performed by Symbia T6 (Siemens Healthcare) SPECT imager. We used DaTView, as a quantitative analysis software. We compared retrospectively these I-123 FP-CIT SPECT findings, MRI findings, and clinical symptoms.

Results In Case 1: I-123 FP-CIT SPECT showed normal findings, although progressive symptoms of parkinsonism and abnormal accumulation of iron in the globus pallidus were observed by brain MRI. In Case 2 and 3: the results of I-123 FP-CIT SPECT showed asymmetrical uptake findings, even though there is no difference between right and left in movement disorder.

Conclusions We evaluated the result of I-123 FP-CIT SPECT in case 1 was normal. Case 2 and 3, normal findings or symmetrical findings was expected in I-123 FP-CIT SPECT, but recognized laterality for accumulation. There isn’t the normal database of children, so the judgments of case 2 and 3 were difficult. It is necessary to accumulate knowledge continuously.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The experience of the dopamine transporter SPECT in three pediatric patients with Neurodegeneration with Brain Iron Accumulation
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The experience of the dopamine transporter SPECT in three pediatric patients with Neurodegeneration with Brain Iron Accumulation
Ikuko Mochida, Eku Shimosegawa, KEIKO MATSUNAGA, Tadashi Watabe, Kayako Isohashi, Mitsuaki Tatsumi, Hiroki Kato, Jun Hatazawa
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1786;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The experience of the dopamine transporter SPECT in three pediatric patients with Neurodegeneration with Brain Iron Accumulation
Ikuko Mochida, Eku Shimosegawa, KEIKO MATSUNAGA, Tadashi Watabe, Kayako Isohashi, Mitsuaki Tatsumi, Hiroki Kato, Jun Hatazawa
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1786;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties Track

  • Quantitative Evaluation of Parathyroid Adenoma and Hyperplasia in Reference to Thyroid using Tc-99m MIBI SPECT/CT
  • A primitive study for clinical application of 18F-AlF-NOTA-octreotide PET/CT in combination with 18F-FDG PET/CT for imaging neuroendocrine neoplasms
  • Role of 18F-FDG PET/CT in detection of disease burden and response assessment in patients with myeloid sarcoma
Show more General Clinical Specialties Track

MTA II: Pediatrics Posters

  • The clinical impact of 18F-FDG PET/CT in pediatric germ cell tumors.
  • Relationship of the I-123 Metaiodobenzylguanidine (MIBG) Uptake and Early Relapse of Neuroblastome Using Semi-quantitative Analysis of SPECT/CT
  • Pediatric 99mTc-DMSA Renal SPECT: Electronic Lesion Insertion of Focal Renal Defects for Dose Optimization
Show more MTA II: Pediatrics Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire